Atlas Trials

Chemotherapy for Potentially Resectable Locally Advanced Esophagogastric Junction Carcinoma

Clinical trial NCT03211377 · UNKNOWN

Trial details

NCT number
NCT03211377
Sponsor
Anyang Tumor Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Esophagogastric Junction Cancer
Start date
2017-03-29
Primary completion
2019-03-29
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.